BSE filing, NSE: AAREYDRUGS. Summary written from the filing by ALFA Finder's alert engine.
Aarey Drugs & Pharmaceuticals Ltd: key numbers
- Share price
- ₹108.05
- Market cap
- ₹306.4 Cr
- Revenue (annual)
- ₹472.3 Cr
- Net profit (annual)
- ₹3.97 Cr
- P/E (TTM)
- 73.4×Sector 46.1×
- Promoter holding
- 41.45%+3.74% QoQ
- FII holding
- 4.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aarey Drugs & Pharmaceuticals Ltd
All →Aarey Drugs & Pharmaceuticals Other Announcement
Aarey Drugs & Pharmaceuticals Ltd filed its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI regulations.
Aarey Drugs & Pharmaceuticals Capital Structure Change
Aarey Drugs approved allotment of 1,150,000 equity shares from warrant conversion at ₹47.85 each, receiving ₹5.50 Crore. Issued capital rises to 31,874,303 shares.
- Value
- ₹5.50 Cr
Aarey Drugs & Pharmaceuticals Capital Structure Change
Promoter and promoter group of Aarey Drugs & Pharmaceuticals Ltd acquired 23.70 lakh shares following the conversion of warrants. The acquisition increased their stake by 4.81%.
- Promoter stake change
- +4.81%
Aarey Drugs & Pharmaceuticals Capital Structure Change
Aarey Drugs allotted equity shares to promoters following the conversion of 23,40,000 warrants. This capital structure change increases the promoters' equity stake in the company.
- Value
- ₹11.20 Cr
Aarey Drugs & Pharmaceuticals Annual General Meeting
Aarey Drugs & Pharmaceuticals Ltd. held its 36th Annual General Meeting on September 30, 2026, to conduct business including financial statement adoption and director re-appointment.
Aarey Drugs & Pharmaceuticals Capital Structure Change
Aarey Drugs & Pharmaceuticals Ltd approved the allotment of 11,50,000 equity shares following the conversion of warrants. The allotment aggregate value is Rs. 7.34 Crore.
- Value
- ₹7.34 Cr
Other financial results announcements
All →Vaibhav Global Q2 FY27 Results: Net Profit ₹41.7 Cr, Down 12.4% YoY
Vaibhav Global Ltd reported revenue from operations of ₹938.4 Cr (+7.0% YoY) and net profit of ₹41.7 Cr (-12.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹41.7 Cr · -12.4% YoY
MosChip Technologies Q2 FY27 Results: Net Loss of ₹30.4 Cr
MosChip Technologies Ltd reported revenue from operations of ₹119.1 Cr (-18.9% YoY) and a net loss of ₹30.4 Cr for Q2 FY27.
- Key figure
- Net loss ₹30.4 Cr
OnMobile Global Q2 FY27 Results: Net Loss of ₹10.5 Cr
OnMobile Global Ltd reported revenue from operations of ₹127.1 Cr (-0.9% YoY) and a net loss of ₹10.5 Cr for Q2 FY27.
- Key figure
- Net loss ₹10.5 Cr
Zensar Technologies Q2 FY27 Results: Net Profit ₹190.2 Cr, Up 4.4% YoY
Zensar Technologies Ltd reported revenue from operations of ₹1,585 Cr (+11.5% YoY) and net profit of ₹190.2 Cr (+4.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹190.2 Cr · +4.4% YoY
GMR Airports Q2 FY27 Results: Net Profit ₹65.4 Cr, Up 86.3% YoY
GMR Airports Ltd reported revenue from operations of ₹4,095 Cr (+11.6% YoY) and net profit of ₹65.4 Cr (+86.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹65.4 Cr · +86.3% YoY
Hexaware Technologies Q2 FY27 Results: Net Profit ₹429.4 Cr, Up 16.1% YoY
Hexaware Technologies Ltd reported revenue from operations of ₹3,933 Cr (+12.9% YoY) and net profit of ₹429.4 Cr (+16.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹429.4 Cr · +16.1% YoY